0001401914-17-000003.txt : 20170728 0001401914-17-000003.hdr.sgml : 20170728 20170728161923 ACCESSION NUMBER: 0001401914-17-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170728 DATE AS OF CHANGE: 20170728 EFFECTIVENESS DATE: 20170728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291740 FILM NUMBER: 17990241 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-769-9145 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 D 1 primary_doc.xml X0708 D LIVE 0001401914 Dare Bioscience, Inc. 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA CALIFORNIA 92037 858-769-9145 DELAWARE Cerulean Pharma Inc. Tempo Pharmaceuticals Inc Corporation true Sabrina Martucci Johnson c/o Dare Bioscience, Inc. 11119 North Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Roger L. Hawley c/o Dare Bioscience, Inc. 11119 North Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director Robin J. Steele c/o Dare Bioscience, Inc. 11119 North Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director Susan L. Kelley c/o Dare Bioscience, Inc. 11119 North Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director William H. Rastetter c/o Dare Bioscience, Inc. 11119 North Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director Lisa Walters-Hoffert c/o Dare Bioscience, Inc. 11119 North Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Executive Officer Biotechnology Decline to Disclose 06b false 2017-07-19 false true true true true Reference is made to that certain Proxy Statement filed by the Issuer with the Securities and Exchange Commission on June 19, 2017 (File No. 001-36395), as supplemented. 0 20691388 20691388 0 false 18 0 0 0 false Dare Bioscience, Inc. /s/ Sabrina Martucci Johnson Sabrina Martucci Johnson President and Chief Executive Officer 2017-07-28